AstraZeneca PLC (AZN)

11,002.0
+34.0(+0.31%)
  • Volume:
    1,154,871
  • Bid/Ask:
    10,800.0/11,328.0
  • Day's Range:
    10,806.0 - 11,094.0

AZN Overview

Prev. Close
10,968
Day's Range
10,806-11,094
Revenue
34.19B
Open
10,938
52 wk Range
8,029-11,289.6
EPS
-0.816
Volume
1,154,871
Market Cap
170.47B
Dividend (Yield)
221.70
(2.02%)
Average Volume (3m)
1,931,457
P/E Ratio
-159.09
Beta
0.119
1-Year Change
29.39%
Shares Outstanding
1,549,489,389
Next Earnings Date
Nov 09, 2022
What is your sentiment on AstraZeneca?
or
Market is currently closed. Voting is open during market hours.

AstraZeneca PLC News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

AstraZeneca PLC Analysis

AstraZeneca PLC Company Profile

AstraZeneca PLC Company Profile

Employees
83100

AstraZeneca PLC is a patient-focused pharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines. The Company is focused on various therapy areas, such as Oncology; BioPharmaceuticals (comprising Cardiovascular, Renal & Metabolism (CVRM) and Respiratory & Immunology (R&I)), and Rare Disease. Its pipeline forms a robust portfolio of investigational therapies in various stages of clinical development. Its pipeline includes the Alexion Rare Disease portfolio and comprises approximately 177 projects, of which 161 are in the clinical phase of development. Its key marketed oncology products include Tagrisso (osimertinib), Lynparza (olaparib), Imfinzi (durvalumab), Koselugo (selumetinib), Farxiga/ Forxiga (dapagliflozin), Roxadustat, Onglyza (saxagliptin) and others. The Company’s geographical segments include United Kingdom, Rest of Europe, The Americas and Asia, Africa & Australasia.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralBuyStrong BuyStrong Buy
Technical IndicatorsStrong SellSellStrong BuyStrong BuyStrong Buy
SummaryStrong SellNeutralStrong BuyStrong BuyStrong Buy